ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637651 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637651; 2) Community: the network communities that were significantly associated with the response to NSC 637651; 3) Molecule: the relationships between components within communities and NSC 637651; 4) MDR: the compounds that were significantly associated with the NSC 637651.

NSC Compound Enrichment Correlation
NSC 179187 Salasdine 0.0228801759885687 0.16324609
NSC 622124 Molybdate(6-), hexatriaconta-.mu.-oxooctadecaoxobis[.mu.9-[phosphato(3-)-.kappa.O:.kappa.O:.kappa.O:.kappa.O':.kappa.O':.kappa.O'':.kappa.O'':.kappa.O''':.kappa.O''']]octadeca-, hexapotassium (9CI) 0.0228801759885687 0.21910936
NSC 626390 Null 0.0228801759885687 0.18948621
NSC 629 Bioxiran 0.0228801759885687 0.20797855
NSC 637729 Naphthalene-1,2-dione, 1,2-dihydro-4-[(3-pyridinyl)amino]- 0.0228801759885687 -0.025691143
NSC 655901 ANTINEOPLASTIC-655901 0.0228801759885687 -0.071564039
NSC 656206 Discorhabdin I 0.0228801759885687 -0.067291238
NSC 673267 IL4(38-37)-PE38KDEL 0.0228801759885687 0.11575242
NSC 676963 3-Azido-10-[4-(4-(4-benzoylphenyl)methyl)-1-piperazinyl)butyl]phenothiazine, bismaleate salt 0.0228801759885687 -0.2515209
NSC 681643 Camptothecin Derivative 0.0228801759885687 0.31665572
Total:63  Current:26    [First] [Prev] [Next] [Last]